Nutraceuticals is Fastest Growing Segment Fueling the Growth of Allergic Rhinitis Treatment Market
 |
| Allergic Rhinitis Treatment Market |
The global Allergic Rhinitis
Treatment Market is estimated to be valued at US$ 18.17 Mn in 2023 and is
expected to exhibit a CAGR of 4.1% over the forecast period 2023 to 2030, as
highlighted in a new report published by Coherent Market Insights.
Market Overview:
Allergic rhinitis is a condition
caused by an overreaction of the immune system to substances in the air. Common
symptoms include sneezing, a runny nose, nasal congestion, and an itchy nose or
throat. Nutraceuticals like vitamins, minerals, and botanical supplements
provide relief without the side effects of drug options.
Market Key Trends:
The adoption of nutraceuticals
for allergic rhinitis treatment is growing rapidly. Nutraceuticals offer a
natural and effective option for managing seasonal and perennial allergic
rhinitis symptoms. Butterbur is a popular herb that has been shown to inhibit
the release of histamines and leukotrienes that cause rhinitis symptoms.
Quercetin is a bioflavonoid that reduces inflammation in the nasal passages.
Vitamin C and magnesium are also commonly used to reduce nasal congestion and
other symptoms. Nutraceuticals provide multi-targeted relief through several
biological pathways making them appealing as both a stand-alone treatment and
supplement to prescription medication.
Segment Analysis
The global allergic rhinitis
treatment market is segmented based on treatment, route of administration,
distribution channel, and geography. By treatment, the market is divided into antihistamines,
corticosteroids, decongestants, immunotherapies, and others. Among these, the
antihistamines segment dominates the market due to their easy availability and
effectiveness in controlling rhinitis symptoms such as sneezing, itching, nasal
congestion, and runny nose.
Key Takeaways
The Global
Allergic Rhinitis Treatment Market Size is expected to witness high
growth, exhibiting CAGR of 4.1% over the forecast period, due to increasing
environmental pollution and rising incidences of grass and airborne allergies.
Regional analysis:
North America dominates the
market, accounting for around 40% share. This is attributed to the growing
patient population, availability of advanced treatment options, and presence of
major key players in the region. Asia Pacific is expected to exhibit the
fastest growth during the forecast period owing to rising air pollution levels,
growing awareness regarding rhinitis treatment, and improving healthcare
infrastructure in emerging economies.
Key players:
Key players operating in the
allergic rhinitis treatment market are Merck & Co., Inc., Boehringer
Ingelheim International GmbH, AstraZeneca, GSK plc., Johnson & Johnson
Services, Inc. Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V.,
Aytu BioPharma, Inc., Glenmark Pharmaceuticals Ltd, Himalaya Wellness Company,
Regeneron Pharmaceuticals Inc., Allergy Therapeutics, Stallergenes Greer, Bayer
AG.
Get More Insights Here
https://www.newsstatix.com/allergic-rhinitis-treatment-market-share-size-forecast-outlook-2023-2030/
Comments
Post a Comment